Fernandez-Diaz, Amaya B <br/><br/>
Eye immune privilege? Nivolumab plus ipilimumab: successful treatment in a patient with cutaneous melanoma and ocular metastases.  [electronic resource] 

 -  Melanoma research  06 2019 
 - 345-347 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1473-5636 
<br/><br/><label>Standard No.: </label>10.1097/CMR.0000000000000591  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal<br/>Humans<br/>Immune Privilege<br/>Immunotherapy<br/>Ipilimumab<br/>Melanoma<br/>Nivolumab<br/>Skin Neoplasms